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Abstract
Background: Taurine is present in lymphocytes and seems to modulate certain immune cell functions. Among the
effects of taurine on these cells are protection against antioxidants and regulation of inflammatory aspects of the
immune response. Stress affects antigen presentation, traffic and proliferation of leukocytes, as well as antibody
and cytokine secretion. The purposes of this study were to explore the possible direct effects of taurine
concentrations on lymphoproliferation and interleukins levels in control and in physical restrained rats.
Methods: Lymphocytes of male Sprague-Dawley rats, stressed by physical restrain and controls (5 h per day for
5 days) were isolated from blood by Histopaque (1077 g/l) and differential adhesion to plastic, and then cultured
(72 h) in the presence of different concentrations of taurine (0.5 – 50 mM), b-alanine (0.5 – 50 mM), or both,
without or with the T cells mitogen, concanavalin A. Plasma and lymphocytes levels of pro-inflammatory
interleukin-1b and anti-inflammatory interleukin-10 were respectively measured by Pierce Endogen rat ELISA Kits.
Taurine in plasma and in lymphocytes were determined by HPLC.
Results: Lymphoproliferation of resting cells significantly decreased in the presence of 3 and 6 mM taurine and
increased up to control level at 12 mM taurine. In concanavalin A-activated lymphocytes, the effect of taurine was
greater. b-alanine increased lymphoproliferation in a bell shaped dose-dependent manner and decreased it in
activated lymphocytes but in a lower magnitude. In combination, b-alanine impaired the effect of taurine at 3 and
6 mM. After restriction, no change in lymphoproliferation was observed at different concentrations of the amino
acids without or with concanavalin A, although pro-inflammatory interleukin and taurine in plasma and in
lymphocytes significantly increased.
Conclusions: Taurine affects lymphoproliferation in control rats, following a dose-dependent manner, an effect
that might involve its transport into the cells. Elevation of interleukin-1b produced in stressed rats by physical
restrain could seriously affect the immune balance, whereas taurine increase might be protective. These results
suggest that taurine and taurine transport play a role in lymphoproliferation. In addition, modifications of taurine
system in lymphocytes take place during restriction stress.
Introduction
Taurine (TAU) and taurine transporter (TAUT) are pre-
sent in lymphocytes [1,2]. One of the functions of TAU
in these cells might be related to protection against oxi-
dants [3], regulation of pro-inflammatory cytokines in
humans and formation of taurine cloramine (Tau-Cl)
[4]. Exogenous TAU was shown to possess significant
anti-inflammatory properties in various in vivo and in
vitro models of inflammation, and to protect the tissues
by increasing the defending capacity of organs against
oxidative damage in inflammatory bowel disease, pan-
creatitis, and gastric mucosal injury [5,6]. This anti-
inflammatory action of TAU was shown to be a direct
result of its antioxidant effects, which inhibits lipid per-
oxidation and neutrophil activation [5]. The effect of
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TAU in combating oxidative damage is well known to
result from its ability to scavenge hypochlorous acid
generated in neutrophils in the process of phagocytosis
to form the relatively harmless Tau-Cl [7]. Tau-Cl inhi-
bits the activation of nuclear factor B, a potent signal
transducer for inflammatory cytokines [8].
Physical restraint a well know stress model, increases
oxidative processes [9], reduces T lymphocyte prolifera-
tion in response to concanavalin A (Con A), decreases
the number of CD4+ T cell subpopulation without
changes in CD8+ T cells, impairs T helper component
of immunity [10], and could induce an elevation of
plasma interkeukin 6, tumor necrosis factor-a (TNF-a)
and interferon g [11-13].
The purposes of this study were to explore the possi-
ble direct effects of TAU on lymphoproliferation as well
as levels of TAU, and pro- and anti-inflammatory inter-
leukins in physically restrained rats and its controls.
Methods
Animals and stress procedures
Male Sprague–Dawley rats (Rattus norvegicus) ranging
in weight from 200 to 250 g were obtained from the
hatchery of Instituto Venezolano de Investigaciones
Científicas (IVIC). The animals were housed individually
in a room controlled for temperature, humidity and
lighting. Commercial rat food and water were available
ad libitum. All manipulations followed international
ethical guide [14]. Rats were stressed by restraint in
an immobilization conical tube of 50 ml (restrainer)
with ventilation holes for 5 hours and for 5 consecutive
days. All stress procedures occurred from 11:00 am to
4:00 pm.
Preparation of blood peripheral lymphocytes
The rats were anesthetized with ether and blood sam-
ples were taken by intracardiac puncture between 10:00
and 11:00 am in tubes with EDTA, 1.8 mg/ml. The
blood was centrifuged at 1000 rpm with a vasculant
rotor for 10 min at room temperature. The plasma was
collected for determination of interleukins and amino
acid analysis, and the layer of white cells plus some red
blood cells was taken and transferred to tubes with 10
ml of isotonic saline 0.1 M sodium phosphate buffer pH
7.4 (PBS). These suspensions were placed on 3 ml of
Histopaque (Sigma) (1077 g/l). After centrifugation at
2000 rpm for 30 min peripheral mononuclear cell layer
was taken, washed twice with PBS and centrifuged at
1200 rpm for 10 min. To achieve enriched lymphocyte
preparation with a minimal monocyte contamination.
The resulting pellet was diluted with Roswell Park
Memorial Institute Medium 1640 (RPMI) free of bovine
serum albumin and incubated in a plastic flask for
45 min at 37° C and 5% of CO2. After the incubation,
lymphocytes, which are non-adherent cells (80–90%),
were dislodged from adherent monocytes, transferred to
plastic tubes and washed twice. The integrity of isolated
lymphocytes was determined by Trypan blue exclusion
test and was greater than 90%.
Lymphoproliferation assay
Lymphocytes were cultured in 96 well plaques, in which
200,000 cells were placed in each one to a final volume
of 200 µl of RPMI medium with gentamicin (100 µg/
ml), L-glutamine (2 mM) and 10% fetal calf serum
(Gibco BRL, Maryland). The incubation was performed
at 37° C, 5% CO2 and 100% humidity for 72 h in the
absence or in the presence of Con A at suboptimal con-
centration, 2 µg/ml. TAU (1.5–24 mM) and b–alanine
(b-Ala) (0.8-50 mM) ware added to the cultures. Prolif-
eration was measured with 3-[4,5-dimetilazol-2-il]-2,5-
diphenil-tetrazolio (MTT) (Sigma, St Louis, MO)
(19,20). MTT was prepared in PBS, 5 mg/ml, 20 µl was
added to each well, and incubation was done for 4 h at
37°C. Then, 100 µl of solution was extracted and 100 µl
of HCl 0.04 N in isopropanol was added. After mixing,
the plaque was read in a GENios lector (Tecan) at
570 nm with the Program Magellan.
Measurement of plasma interleukin-1b and interleukin-10
Plasma collected for interleukin-1b (IL-1b) and interleu-
kin-10 (IL-10) assays was stored at -80°C. The levels of
IL-1b and IL-10 were measured by ELISA Endogen kits
(Pierce Endogen, Cambridge, MA) following the manu-
facturer’s instructions. Briefly, 100 µl of samples were
dispensed into 96 wells coated with rat IL-1b or IL-10
antibody and incubated for 2 hours at room tempera-
ture. After extensive washing, 100 µl of the biotinylated
anti-IL-1b (or IL-10) were added to each well, and
plates were incubated for 30 min at room temperature.
The wells were again washed 5 times, 100 µl of Strepta-
vidin-HRP was added and incubation was done for 30
min. 3,3´,5,5´-tetramethylbenzidine (TMB) (100 μL/well)
was used as the chromogen for the colorimetric assay.
The reaction was stopped by adding 100 µl/well of stop
solution and the absorbance was read at 450 nm. The
levels of ILs are expressed as pg/ml.
Determination of taurine
TAU in plasma and in lymphocytes was determined by
high performance liquid chromatography (HPLC) with
fluorescent detection employing a modified method (16).
The HPLC system consisted of a Waters 2690 Separation
System and a Shimadzu RF-551 fluorescent detector. A
Sulpeco LC-18 column 4.6 X 100 mm, 5 µm was
employed for amino acid separation. Platelet poor
plasma, 300 µl, was acidified with 50 µl of 20% sulfosa-
licylic acid. Centrifugation was carried out at 17,000 rpm
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for 20 min, at 4°C, and supernatant was kept at 80°C
until chromatographic analysis. Immediately before injec-
tion, 50 µl of the supernatants plus 150 µl of potassium
borate buffer pH 10.4 and 200 µl of the mixture: 25 mg
o-phtaldehyde, 500 µl methanol, 25 µl b-mercaptoethanol
(1 g/ml), and 4.5 ml 0.4 M potassium borate buffer pH
10.4 was used for derivatization. Then, 15 µl of the deri-
vatized preparation were injected into the chromato-
graphic system. The levels of amino acids were calculated
from the area under the curve of samples and external
standards with program Millenium, and expressed as
nmol/ml.
Analysis of data
Data are expressed as the arithmetic mean ± standard
error of the mean (SEM). Differences were statistically
analyzed using the Student’s t-test. Statistical
significance was considered if P < 0.05. Data manage-
ment and statistical analysis were conducted employing
the program Microsoft Office Excel 2007.
Results and discussion
Lymphoproliferation
Figure 1A shows that lymphoproliferation of control rats
significantly decreased in the presence of 3 mM TAU
and reached basal levels at 6 mM TAU. While in Con
A- activated lymphocytes, there is also a significant
decrease a 3 mM, but it remains low in the following
concentrations. In restrained rats (Figure 1B) there were
no statistical changes in activated lymphocytes, and rest-
ing showed a significant increase at 3 and 6 mM, but
returned to basal values at greater concentrations. The
Figure 2 shows that to values above 6 mM b-Ala
the lymphoproliferation significantly increased In Con
Figure 1 Effect of taurine (TAU) on lymphoproliferation in the absence and in the presence of concanavalin A (Con A), A) in control
rats, and B) in physical restrained rats. Each value represents the mean ± SEM, n = 6. * P < 0.05 respecting corresponding Basal. ** P < 0.05
respecting Without TAU Basal. *** P < 0.05 respecting Without TAU Con A.
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A- activated lymphocytes, there was a significant
decrease between 1,5 and 6 mM and reached basal
levels unactivated. However, at higher concentrations
when the values of lymphoproliferation were again sta-
tistically similar to basal of Con A, we observed that the
effect decreased to a lesser extent in Con A-activated
lymphocytes (Figure 2).
Protein kinase C (PKC) isoforms plays an important
role in lymphoproliferation. PKC-θ, is a crucial regulator
of T-cell activation and proliferation as well as of cyto-
kine production [15-17]. Moreover, PKC-a is also
involved in T-cell proliferation acting upstream of PKC-
θ [18,19]. In addition, Tau has been shown to affect
PKC isoforms, regulating their activity an expression in
a concentration-dependent manner [20,21], and it is
possible that the observed response in lymphoprolifera-
tion is due to the effect of Tau on PKC isoforms and/or
inhibition of the nuclear translocation of NF-kappaB by
inhibition of PKC-a expression [19]. However, TAU
also regulates the phosphorylation of TAUT, through
PKC as an adaptive response to changes in TAU avail-
ability [22-24], so maybe TAUT plays an important role
in the lymphoproliferation.
On the other hand, since previous studies show that
inhibitors of PKC suppress mitogen induced T-cell pro-
liferation [25], it is possible that Tau acts as an inhibitor
of PKC at concentrations above 3 mM, and therefore
the effect in lymphoproliferation is more prominent in
Con A activated- lymphocytes.
Previous studies have demonstrated that physical
restrain decreases peripheral blood lymphocyte and
mitogen-induced proliferation in rats and produces
changes in T cell functional capacity [26,10]. In the pre-
sent study, decreased response of lymphoproliferation
was not observed in restrained rats. In addition, no dif-
ferences were present with variable TAU concentration
which could indicate that immune modifications due to
physical restrain might be regulated by TAU, possibly
through its effect on PKC isoforms.
To better assess the effect of TAUT on the lympho-
cyte proliferation the TAUT antagonist, b-Ala, was used
[27]. In these experiments, at low concentrations of b-
Ala lymphoproliferation remains at values similar to
basals, but with increasing concentrations, lymphoproli-
feration significantly increased. It might be that incom-
plete inhibition of TAUT at low concentrations of
b-Ala, in contrast to the effects observed at higher con-
centrations of this amino acid could be responsible for
the differential modulation of lymphocytes proliferation.
However, Con A-treated lymphocytes displayed a resis-
tance to the influences of TAU or b-Ala, probably indi-
cating a particular condition of TAUT due to the
unspecific activation by the mitogen.
Plasma levels of interleukine-1b and interleukine-10
The concentration of the proinflammatory IL-1b signifi-
cantly increased in restrained rats, reaching concentra-
tions more than double those of controls, while the
Figure 2 Effect of b-alanine (b-Ala) on lymphoproliferation in the absence and in the presence of concanavalin A (Con A) in control
rats. Each value represents the mean ± SEM, n = 6. * P < 0.05 respecting corresponding Basal. ** P < 0.05 respecting Without b-Ala Basal. *** P
< 0.05 respecting Without b-Ala Con A.
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anti-inflammatory IL-10 remained unchanged in con-
trols and in restrained rats (Fig. 3).
Physical restraint is known to activate hypothalamic-
pituitary-adrenal (HPA) axis, resulting in transiently
increased release of glucocorticoids and IL-6 [28,29].
Findings by in vitro studies indicate that IL-6 produces
upregulation of IL-1b mRNA in human T cells, and
this positive feedback by IL-6 on IL-1b secretion
occurs after or during stress as a mechanism of par-
tially reducing the downregulatory effect of corticoster-
one on IL-1b [12]. Moreover, IL-1b, together with
TNF-a and IL-6 influence the HPA axis, resulting in
increased levels of glucocorticoids in physically
restrained rats [30,31]. On the other hand, IL-6 is a
pleiotropic interleukin that has multiple functions,
including stimulatory effects on proliferation and dif-
ferentiation of lymphocytes [32], and could be one of
the factors influencing lymphoproliferation.
Plasma and lymphocytes taurine concentration
Figure 4A and 4B represent the levels of TAU in plasma
and in lymphocytes, respectively, which significantly
increased in restrained rats. Physical restraint leads to
hyper-oxidant reaction, and hence in an imbalance
between pro-oxidant and anti-oxidant forces [9], as well
as increase in proinflamatory cytokines [13]. It is possi-
ble that the increase of plasma TAU could be involved
in protection against oxidants and in regulation of pro-
inflammatory cytokines production by the formation of
Tau-Cl.
Previous studies have shown that high concentrations
of TAU reduced the expression, activity and nuclear
localization of TAUT, whereas low levels increase them
[23]. This is due to TAU affects the phosphorylation of
specific proteins through PKC [22,33], TAUT, which is
regulated by PKC phosphorylation in serine 322 at the
post-translational level [34] as an adaptive response to
changes in TAU availability. It might be that TAUT
could be lower in restrained rats, then produce a tem-
poral increase of TAU in the circulation as a regulatory
response. Moreover, the increased values of TAU in
lymphocytes could be linked to changes in TAUT.
At the present, studies on TAUT capacity and expres-
sion are undertaken in restrained rats.
Conclusions
Results in culture at different conditions suggest that
TAU system plays a differential role in lymphoprolifera-
tion, related to concentration, and that physical restraint
produces alterations that influence TAU effects. Con-
centrations of IL-1b were elevated in plasma of rats
after physical restraint, which indicate modifications
during stress that could trigger pathological changes.
The significant increase of TAU levels in plasma and in
lymphocytes are probably related to known protective
effects of TAU, and might be the result of TAUT
changes.
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